drugset / Trial / NCT05692934
A HR20031 FE Study on Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to assess the effect of food on the single-dose PK of SHR3824, SP2086 and metformin in the HR20031 FDC tablets in healthy subjects.
Timeline
- Start
- 2023-01-31
- Primary completion
- 2023-03-11
- Completion
- 2023-03-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Henagliflozin | Small molecule | 10 mg | — |
| Subject | Metformin | Small molecule | 1000 mg | — |
| Subject | Metformin | Small molecule | 1500 mg | — |
| Subject | Retagliptin | Small molecule | 100 mg | — |